Development of smokeless tobacco-induced oral mucosal lesions

Journal of Oral Pathology and Medicine

Volumn 27, Issue 8, 1998, Pages 388-394

  Johnson, Georgia K ^a,d   Payne, Jeffrey B ^b   Fili, James M ^a   Reinhardt, Richard A ^b   Organ, Connie C ^a   Slager, Susan L ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Eicosanoids; IL 1; Oral mucosa; Tobacco, smokeless adverse effects

Indexed keywords

EID: 0032169287     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01972.x     Document Type: Article

References (42)

1. GREER RO, POULSON TC. Oral tissue alterations associated with the use of smokeless tobacco by teen-agers, Part I. Clinical findings. Oral Surg Oral Med Oral Pathol 1983; 56: 275-84.
2. POULSON TC, LINDENMUTH JE, GREEK JR RO. A comparison of the use of smokeless tobacco in rural and urban teenagers. CA Cancer J Clin 1984; 34: 248-61.
3. ROBERTSON PB, WALSH M, GREENE J, ERNSTER V, GRADY D, HAUCK W. Periodontal effects associated with the use of smokeless tobacco. J Periodontol 1990; 61: 438-3.
4. AXELL T, MORNSTAD H, SUNDSTROM B. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J Oral Pathol 1976; 5: 229-36.
5. ANDERSSON G, AXELL T. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med 1989; 18: 2-7.
6. 2, interleukin-lα and interleukin-1β. J Periodontol 1995; 66: 177-83.
7. 2 and IL-1β. J Periodontol 1994; 65: 937-1.
8. 2 and interleukin-1. J Periodontol 1996; 67: 116-24.
9. FURSTENBERGER G. Role of eicosanoids in mammalian skin. In: BARBERA-GUILLEM E, ed. Cell biology reviews. University of the Basque Country: Springer International, 1990; 24: 1-90.
10. MCKENZIE RC, SAUDER DN. The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 1990; 95 105S-7S.
11. Down PM, BLACK AK, WOOLLARD PM, CAMP RDR, GREAVES MW. Cutaneous responses to 12-hydroxy-5-8,10,14-eicosatetrenoic acid (12-HETE). J Invest Dermatol 1985; 84: 537-1.
12. PINDBORG JJ, RENSTRUP G. Studies in oral leukoplakias. II. Effect of snuff on oral epithelium. Acta Derm Venereol 1963; 43: 271-6.
13. ANDERSSON GA, AXELL T, LARSSON A. Histologic changes associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med 1989; 18: 491-7.
14. FRITHIOF L, ANNEROTH G, LASSON U, SEDERHOLM C. The snuff-induced lesion. A clinical and morphological study of a Swedish material. Acta Odontol Scand 1983; 41: 53-64.
15. HIRSCH JM, HEYDEN G, THILANDER H. A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol 1982; 11: 387-98.
16. GREER RO, POULSON TC, BOONE ME, LINDENMUTH JE, CROSBY L. Smokeless tobacco-associated oral changes in juvenile, adult and geriatric patients: clinical and histomorphologic features. Gerodontic 1986; 2. 87-98.
17. DANIELS TE, HANSEN LS, GREENSPAN JS, et al. Histopathology of smokeless tobacco lesions in professional baseball players. Oral Surg Oral Med Oral Pathol 1992; 73: 720-5.
18. 2 and interleukin-1 levels in smokeless-tobacco induced oral mucosal lesions. J Periodont Res 1994; 29: 430-8.
19. RAMJFORD SP. Indices for prevalence and incidence of periodontal disease. J Periodontol 1959; 30: 51-9.
20. SILNESS J, LOE H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22: 121-35.
21. LOE H, SILNESS J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21: 533-51.
22. POWELL WS. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol 1982; 86: 467-77.
23. OFFENBACHER S, ODLE MD, MAYAMBALA MA, et al. Inhibition of human periodontal prostaglandin E2 synthesis with selected agents. Agents Actions 1990; 29: 232-8.
24. HONIG J, RORDORF-ADAM C, SIEGMUND C, WIEDEMANN W, ERARD F. Increased interleukin-1 beta concentrations in gingiva from periodontitis patients. J Periodont Res 1989; 24: 362-7.
25. CROWDER MJ, HAND DJ. Analysis of repeated measures. London: Chapman and Hall, 1990: 124-7.
26. DUELL EA, ELLIS CN, VOOHEES JJ. Determination of 5-, 12-, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin. J Invest Dermatol 1988; 91: 446-50.
27. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993; 64: 432-44.
28. RISTOW H-J. A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin-1 or a related protein. Proc Natl Acad Sci USA 1987; 84: 1940-4.
29. GILHAR A, PILLAR T, ETZIONI A. Possible role of cytokines in cellular proliferation of the skin transplanted onto nude mice. Arch Dermatol 1995, 131: 38-42.
30. 2 in mouse epidermis in vivo. Biochem Biophys Res Commun 1978; 84: 1103-41.
31. MCCULLOUGH JL, SCHREIBER SH, ZIBOH VA. Cell proliferation kinetics of epidermis in the essential fatty acid deficient rat. J Invest Dermatol 1978; 70: 318-20.
32. PENTLAND AP, NEEDLEMAN P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 1986; 77: 246-51.
33. LUGER TA, SCHWARZ T, KRUTMANN J, et al. Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 1989; 557: 405-14.
34. LARSEN CG, ANDERSON AO, OPPENHEIM JJ, et al. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 1989; 63: 31-6.
35. MEIKLE MC, ATKINSON SJ, WARD RV, MURPHY G, REYNOLDS JJ. Gingival fibroblasts degrade Type I collagen films when stimulated with tumor necrosis factor and interleukin-1 : evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989; 24: 207-13.
36. DINARELLO CA. Biology of interleukin 1. FASEB J 1988; 2: 108-15.
37. 2. J Dent Res 1996; 75: 1558 (abstr).
38. 2 and interleukin-1 concentrations in nicotine-exposed keratinocyte cultures. J Periodont Res 1997; 32: 447-52.
39. 2 and ILIβ release by LPS-treated human monocytes. J Periodont Res 1996; 31: 99-104.
40. PABST MJ, PABST KM, COLLIER JA, COLEMAN TC, et al. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995; 66: 1047-55.
41. GRADY D, ERNSTER V, STILLMAN L, GREENE J, DANIELS TE, SILVERMAN S. Short term changes. A surprise with smokeless tobacco oral lesions. J Am Dent Assoc 1991; 122: 62-4.
42. LARSSON A, AXELL T, ANDERSSON G. Reversibility of snuff dippers' lesion in Swedish moist snuff users: a clinical and histologic follow-up study. J Oral Pathol Med 1991; 20: 258-64.